Advanced searches left 3/3

Catabolic Pathway - Europe PMC

Summarized by Plex Scholar
Last Updated: 10 September 2022

* If you want to update the article please login/register

Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer.

The mechanisms that underpin physiological adaptation of pancreatic ductal adenocarcinoma cells to pharmacologic inhibition of RAS-MAPK signaling are largely unknown. We find transcriptional antagonism between c-MYC and the master transcription factors for lysosome gene expression, the MiT/TFE proteins, based on transcriptome and chromatin immunoprecipitation profiling of PDA cells treated with the MEK inhibitor trametinib. c-MYC and MiT/TFE factors compete for binding to lysosome gene promoters to fine-tune gene expression under baseline conditions. MiT/TFE-dependent lysosome biogenesis is a process that contributes to c-MYC downregulation and increased MiT/TFE-dependent lysosome biogenesis. Ferritinophagy promotes mitochondrial iron-sulfur cluster protein synthesis and improved mitochondrial respiration. During adaptation to KRAS-MAPK inhibition, according to Shunning iron utilization, lowering iron use sensitizes PDA cells to MEKi, undermining a critical and targetable reliance on lysosome-dependent iron supply. Significance Lower c-MYC levels following MAPK pathway suppression may have aided in the upregulation of autophagy and lysosome biogenesis.

Source link: https://europepmc.org/article/MED/35771494

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions